Royal Bank of Canada’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,562
Closed -$214K 7295
2023
Q2
$214K Buy
5,562
+702
+14% +$27K ﹤0.01% 4271
2023
Q1
$113K Sell
4,860
-3,176
-40% -$73.8K ﹤0.01% 4712
2022
Q4
$210K Buy
8,036
+6,816
+559% +$178K ﹤0.01% 4386
2022
Q3
$24K Buy
1,220
+973
+394% +$19.1K ﹤0.01% 5585
2022
Q2
$4K Sell
247
-2,231
-90% -$36.1K ﹤0.01% 6318
2022
Q1
$41K Sell
2,478
-4,996
-67% -$82.7K ﹤0.01% 5744
2021
Q4
$122K Buy
7,474
+4,410
+144% +$72K ﹤0.01% 5262
2021
Q3
$39K Buy
3,064
+882
+40% +$11.2K ﹤0.01% 5787
2021
Q2
$30K Buy
2,182
+1,439
+194% +$19.8K ﹤0.01% 5851
2021
Q1
$11K Buy
+743
New +$11K ﹤0.01% 6284
2020
Q3
Sell
-1,089
Closed -$13K 6467
2020
Q2
$13K Sell
1,089
-453
-29% -$5.41K ﹤0.01% 5277
2020
Q1
$21K Buy
1,542
+1,502
+3,755% +$20.5K ﹤0.01% 5032
2019
Q4
$0 Sell
40
-97
-71% ﹤0.01% 6427
2019
Q3
$1K Sell
137
-18
-12% -$131 ﹤0.01% 5874
2019
Q2
$1K Hold
155
﹤0.01% 5784
2019
Q1
$3K Sell
155
-3
-2% -$58 ﹤0.01% 5466
2018
Q4
$2K Sell
158
-647
-80% -$8.19K ﹤0.01% 5584
2018
Q3
$30K Buy
805
+36
+5% +$1.34K ﹤0.01% 4879
2018
Q2
$27K Buy
769
+92
+14% +$3.23K ﹤0.01% 4842
2018
Q1
$31K Sell
677
-241
-26% -$11K ﹤0.01% 4671
2017
Q4
$34K Sell
918
-613
-40% -$22.7K ﹤0.01% 4617
2017
Q3
$82K Buy
1,531
+1,156
+308% +$61.9K ﹤0.01% 4417
2017
Q2
$22K Sell
375
-158
-30% -$9.27K ﹤0.01% 4763
2017
Q1
$29K Buy
533
+90
+20% +$4.9K ﹤0.01% 4763
2016
Q4
$24K Buy
443
+268
+153% +$14.5K ﹤0.01% 4925
2016
Q3
$11K Sell
175
-49
-22% -$3.08K ﹤0.01% 4998
2016
Q2
$12K Sell
224
-37
-14% -$1.98K ﹤0.01% 4984
2016
Q1
$17K Buy
261
+152
+139% +$9.9K ﹤0.01% 4860
2015
Q4
$15K Buy
109
+34
+45% +$4.68K ﹤0.01% 5078
2015
Q3
$7K Sell
75
-126
-63% -$11.8K ﹤0.01% 5462
2015
Q2
$31K Buy
+201
New +$31K ﹤0.01% 4981